EVA Live Launches NeuroServe, Its Next-Generation AI Online Advertising Platform
Rhea-AI Summary
EVA Live (Nasdaq: GOAI) launched NeuroServe on February 3, 2026, a next-generation AI online advertising platform designed for enterprise-scale campaign optimization. The platform, developed for more than two years and BETA tested in 2025, uses real-time AI learning to automate targeting, reduce manual A/B testing, and improve return on ad spend. Management expects NeuroServe to become the company's leading product by sales by the end of 2026, subject to market conditions and execution. Live demonstrations are available via the company website.
Positive
- Launched NeuroServe on February 3, 2026
- Platform was BETA tested in 2025
- Built for enterprise-scale real-time AI optimization
Negative
- Forecast that NeuroServe will lead sales by end of 2026 is conditional on execution
- Commercial outcomes depend on market conditions and successful scaling
News Market Reaction
On the day this news was published, GOAI declined 8.94%, reflecting a notable negative market reaction. Argus tracked a trough of -14.8% from its starting point during tracking. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $11M from the company's valuation, bringing the market cap to $112M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
GOAI fell 8.67% while close peers were mixed: VRSSF down 1.01%, CYBHF down 5.27%, but RLAIF up 4.44% and RMXI up 0.84%, suggesting stock-specific pressure rather than a broad AI/software move.
Previous AI Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Sep 19 | Website relaunch | Positive | -40.9% | Launch of new AI-focused corporate homepage to showcase solutions and updates. |
| Apr 29 | AI collaboration | Positive | -7.2% | Strategic collaboration to enhance AI-powered content creation capabilities. |
| Mar 14 | AI expansion plans | Positive | +0.0% | Announcement of expanded AI-powered solutions across multiple industries. |
| Mar 11 | QB market approval | Positive | +0.0% | Approval for QB market viewed as a milestone in the company’s AI journey. |
AI-related news has often seen weak or negative next-day moves for GOAI, with prior AI announcements in 2024 twice followed by notable declines despite positive positioning.
Recent AI-tagged announcements for GOAI have focused on positioning the company as an AI innovator, including a new corporate homepage in September 2024, a strategic collaboration in April 2024, broader AI solution expansion in March 2024, and QB market approval in March 2024. Despite these seemingly constructive updates, same-tag events often saw flat or negative next-day price reactions, underscoring a history of cautious market reception to GOAI’s AI narratives.
Historical Comparison
Past AI-tagged announcements for GOAI produced average next-day moves of about 12.02%. This NeuroServe launch continues the pattern of AI-focused positioning aimed at scaling digital advertising performance.
AI-tagged history shows progression from branding and communication (new homepage), to partnerships and broader AI solution expansion, and market listings. NeuroServe’s launch fits as a next step, introducing a core AI advertising platform intended to drive revenue and enterprise-scale adoption.
Market Pulse Summary
The stock moved -8.9% in the session following this news. A negative reaction despite an AI platform launch fits a history where some AI-tagged updates saw weak or adverse moves. The company highlighted a large addressable market, estimated at $500 billion in 2025 and projected above $1.3 trillion, yet markets may be discounting execution risk, prior going-concern disclosures, or skepticism about translating product launches into durable revenue. Past AI news averaged about 12.02% next-day swings, indicating event-driven volatility.
Key Terms
a/b testing technical
real-time ai learning technical
return on ad spend financial
AI-generated analysis. Not financial advice.
Los Angeles, CA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- EVA Live, Inc. (Nasdaq: GOAI), an AI-driven digital advertising company, announces the official launch of NeuroServe, its next-generation online advertising platform built to help advertisers improve performance, reduce inefficiencies in A/B testing and manual errors , and scale campaigns more efficiently using artificial real-time learning intelligence. This equates to a higher rate of return for marketing budgets.
NeuroServe has been in development for more than two years and was BETA tested with online advertisers and lead generators in 2025. The platform was built from the ground up to operate at enterprise scale and improve advertising performance without the complexity and delays of traditional campaign management.
Using real-time AI learning, NeuroServe continuously analyzes how users interact with ads and automatically adjusts delivery and targeting as campaigns run. This approach replaces slow, manual optimization with instant decision-making, reducing human error, accelerating campaign performance, and redefining traditional digital marketing workflows.
Key benefits of NeuroServe include:
- Real-time AI-driven optimization across campaigns
- Higher-quality traffic and lead generation
- Improved return on ad spend with reduced waste
- Automated optimization without manual testing
- Built to support high-volume advertising at scale
The platform was stress-tested with select agencies and lead-generation partners to validate performance, stability, and scalability under real-world traffic conditions.
According to industry research from Grand View Research, the global online advertising market is estimated at approximately
NeuroServe is positioned to become EVA Live’s core revenue-generating product. Based on early demand, platform scalability, and market opportunity, management expects NeuroServe to represent a growing share of EVA Live’s overall revenue and to become the Company’s leading product by sales by the end of 2026, subject to market conditions and execution.
NeuroServe is now available to online businesses, and live demonstrations can be requested through EVA Live’s website at eva.live/nueroserve. The Company has expanded its engineering, product, and go-to-market teams with experienced industry professionals to support platform scalability.
About EVA Live, Inc.
EVA Live, Inc. is an AI technology-driven media and digital solutions company focused on delivering innovative solutions, scalable growth, and long-term shareholder value.
Cautionary Note Regarding Forward-Looking Statements.
This press release contains “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, included herein, including but not limited to such things as future business strategy, plans, and goals, and the expansion and growth of our business. The words “estimate”, “plan”, “anticipate”, “expect”, “intend”, “believe” “target”, “budget”, “may”, “can”, “will”, “would”, “could”, “should”, “seeks”, or “scheduled to” and similar words or expressions, or negatives of these terms or other variations of these terms or comparable language or any discussion of strategy or intention identify forward-looking statements. Please see the risk factors included in the Company’s United States Securities and Exchange Commission filings, which could cause actual results and events to differ materially from those contained in the forward-looking statements. You are cautioned against attributing undue certainty to forward-looking statements. Although these forward-looking statements were based on assumptions that the Company believes are reasonable when made, you are cautioned that forward-looking statements are not guarantees of future performance and that actual results, performance, or achievements may differ materially from those made in or suggested by the forward-looking statements in this press release. Any forward-looking statements made in this press release speak only as of the date of those statements. We undertake no obligation to update those statements or publicly announce the results of any revisions to any of those statements to reflect future events or developments.
Media Inquiries:
Javan Khazali
Phone: 310-229-5981
Email: info@eva.live
FAQ
What is NeuroServe and when did EVA Live (GOAI) launch it?
How was NeuroServe tested before the public launch by EVA Live (GOAI)?
What benefits does NeuroServe offer advertisers and businesses using GOAI?
Will NeuroServe materially affect EVA Live's (GOAI) revenue mix in 2026?
How can businesses request a demonstration of NeuroServe from EVA Live (GOAI)?
